A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Vertex Pharmaceuticals Incorporated
Related studies linked through entity extraction aliases.
A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)
- Status
- COMPLETED
- Phase
- PHASE3
Longitudinal Assessment of Exercise Capacity and Vascular Function in Patients With CF
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy
- Status
- COMPLETED
- Phase
- PHASE2
MUCOviscidose EXacerbation Outils Connectés Education Thérapeutique
- Status
- TERMINATED
- Phase
- NA
Tezacaftor/Ivacaftor Combination Therapy Expanded Access Program for Patients 12 Years of Age and Older With Cystic Fibrosis
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation
- Status
- COMPLETED
- Phase
- PHASE3
A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Simplification of CF-related Diabetes Screening at Home
- Status
- COMPLETED
- Phase
- NA
A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy
- Status
- COMPLETED
- Phase
- PHASE2
A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate Safety, Efficacy, and Tolerability of TEZ/IVA in Orkambi® (Lumacaftor/Ivacaftor) -Experienced Subjects With Cystic Fibrosis (CF)
- Status
- COMPLETED
- Phase
- PHASE3
A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
- Status
- COMPLETED
- Phase
- PHASE3
The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Efficacy of Ivacaftor in Subjects With Cystic Fibrosis Who Have a 3849 + 10KB C→T or D1152H CFTR Mutation
- Status
- COMPLETED
- Phase
- PHASE3
Lumacaftor/Ivacaftor Combination Therapy in Subjects With CF Who Have an A455E CFTR Mutation
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Safety and Pharmacokinetics of VX-659 in Healthy Subjects and in Adults With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of VX-661/Ivacaftor in Pediatric Subjects With Cystic Fibrosis (CF)
- Status
- COMPLETED
- Phase
- PHASE3